Leader: Martin Wehling Eveline van Poelgeest


  1. to create a European network of clinicians and researchers devoted to improve the use of drugs in older subjects
  2. to promote the inclusion of older people in clinical trials
  3. to promote appropriate drug prescription in older people.

Relevance for the purposes of the EuGMS

The aims of the SIG are very relevant for geriatric research and practice.

N° of members: 138

Expected method of work

bi-yearly webinars

Annual meeting in coincidence with the EuGMS congress, email

First expected outcome and approximate date of completion

The systematic review about correlation between polypharmacy and frailty to be submitted within the end of the year

Way of communication among members


Past meetings information

annual meeting in coincidence with the EuGMS congress

19th EuGMS International Congress, Helsinki September 20-22 - SIG Collateral Meeting - OPEN - SEPT 20th from 11.30am to 12.30pm Helsinki TIME

18th EuGMS International Congress, London September 28-30 - SIG Collateral Meeting - PRIVATE - SEPT 29th from 07.00am to 08.30am UK TIME

EuGMS SIG on Pharmacology OPEN online meeting - June 29th

17th EuGMS International Congress, Athens October 11-13 - SIG Collateral Meeting - OPEN- OCT 11th from 06.30pm to 08.00pm CEST

16th EuGMS International Congress, Athens October 7-9

Upcoming webinar

EuGMS SIG on Pharmacology OPEN online meeting – March 19, 2024

20th EuGMS International Congress, Valencia September 18-20, 2024

Recent Publications

  1. Eur J Clin Pharmacol (2021) 77:1-12
  2. Drugs & Aging (2019) 36:299–307 https://doi.org/10.1007/s40266-018-0622-7
  3. Age and Ageing 2020; 1–11, doi: 10.1093/ageing/afaa249, joined activity with the EuGMS Task and Finish Group on Fall-Risk-Increasing Drugs
  4. Optimizing pharmacotherapy and deprescribing strategies in older adults living with multimorbidity and polypharmacy: EuGMS SIG on pharmacology position paper | European Geriatric Medicine (springer.com)
  5. Deprescribing practices, habits and attitudes of geriatricians and geriatricians-in-training across Europe: a large web-based survey | European Geriatric Medicine (springer.com)
  6. The EURO-FORTA (Fit fOR The Aged) List Version 2: Consensus Validation of a Clinical Tool for Improved Pharmacotherapy in Older Adults | Drugs & Aging (springer.com)
  7. joint activity with the EuGMS Task and Finish Group on Fall-Risk-Increasing Drugs: Volume 14, Issue 4 | European Geriatric Medicine (springer.com)

Ongoing SIG projects

  • Development of an evidence-based diuretic deprescribing clinical practice guideline (lead: Eveline van Poelgeest), collaboration between EuGMS SIG Pharmacology, EuGMS SIG cardiovascular disease and deprescribing.org
  • Systematic review on adherence in older people (Jen Stevenson)
  • Guidelines on cardiovascular drugs deprescribing in older adults (lead: Gülistan Bahat), collaboration between EuGMS SIG Pharmacology and EuGMS SIG cardiovascular disease
  • Cross-cultural adaptation and clinical validation of TIME Criteria by TIME International Study Group (lead: Gülistan Bahat)
  • Systematic review on drug side effects and swallowing (lead: Gülistan Bahat)


Dr Wilma Knol and Dr Michael Denkinger are representing EuGMS in the EMA Healthcare Professionals Working Party (HCPWP)